Article
Washington-Although urologists were victorious in a recent courtdecision excluding lithotripsy from the Stark II rule, the U.S. Departmentof Health and Human Services said it will appeal the ruling.
Comparable efficacy seen with single vs. multiple OnabotulinumtoxinA injection sites in OAB
Key updates from the AUA/ASRM male infertility guideline amendment
FDA grants 510(k) clearance to Ambu’s HD cystoscopy solution
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
Category I CPT code granted to irreversible electroporation for prostate lesions
TikTok content on low testosterone lacks information on future risks, study finds